The Duke Human Vaccine Institute (DHVI) and the Department of Surgery at Duke University School of Medicine received a grant from the National Institute of Allergy and Infectious Diseases for HIV vaccine research that could total $25.9 million with full funding over five years.

Transcendental Meditation may help improve the lives of health care workers experiencing burnout, poor sleep, and anxiety symptoms.  

Several Duke Cancer representatives were thrilled to join the founders of the I’m Not Done Yet Foundation, an important partner with DCI’s Teen and Young Adult Oncology Program, to ring the opening bell at Nasdaq on Friday, Oct. 7.

Ernest Mario, PhD, and his family, through the Mario Family Foundation, recently made an important new gift that builds upon their past support and will nurture innovation in health care and patient experience for years to come.

Duke Health leadership launched Translating Duke Health in 2017 as a multi-disciplinary, multi-year commitment to capitalize on Duke’s collective strengths in research, clinical care, and popul

Duke University researchers have developed an RNA-based editing tool that targets individual cells, rather than genes. It is capable of precisely targeting any type of cell and selectively adding any protein of interest. Researchers said the tool could enable modifying very specific cells and cell functions to manage disease.

Two Duke professors are among just eight scholars nationwide who have been awarded prestigious Pioneer Awards this year from the National Institutes of Health (NIH).  

Lee Zou, PhD, has been named the new chair of the Department of Pharmacology and Cancer Biology. He will begin his new role on Feb. 1, 2023.

Brittany Davidson, MD, associate professor in the Department of OB-GYN, Division of Gynecologic Oncology, and the director of gynecologic oncology fellowships, shares how she and her colleagues are approaching goal planning, palliative care, and end-of-life ovarian cancer care.

Raphael Valdivia, PhD, has been named chair of the Department of Immunology, effective Oct. 1, 2022. Dr. Valdivia is the Nanaline H.